Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Expert Consensus on Screening and Assessment of Cognition in Psychiatry

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Neuronal underpinnings of cognitive impairment and - improvement in mood disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Characteristics influencing expected cognitive performance during hypoglycaemia in type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Assessment and treatment of cognitive impairments in patients with affective disorders

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The maternal brain: Neural responses to infants in mothers with and without mood disorder

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  • Roger S McIntyre
  • Nicole Anderson
  • Bernhard T Baune
  • Elisa Brietzke
  • Katherine Burdick
  • Phillipe Fossati
  • Philip Gorwood
  • Catherine Harmer
  • John Harrison
  • Philip Harvey
  • Rodrigo B Mansur
  • Alice Medalia
  • Kamilla Miskowiak
  • Tanya Ramey
  • Carola Rong
  • Joshua D Rosenblat
  • Allan Young
  • Stephen M Stahl
Vis graf over relationer

During the past two decades, it has been amply documented that neuropsychiatric disorders (NPDs) disproportionately account for burden of illness attributable to chronic non-communicable medical disorders globally. It is also likely that human capital costs attributable to NPDs will disproportionately increase as a consequence of population aging and beneficial risk factor modification of other common and chronic medical disorders (e.g., cardiovascular disease). Notwithstanding the availability of multiple modalities of antidepressant treatment, relatively few studies in psychiatry have primarily sought to determine whether improving cognitive function in MDD improves patient reported outcomes (PROs) and/or is cost effective. The mediational relevance of cognition in MDD potentially extrapolates to all NPDs, indicating that screening for, measuring, preventing, and treating cognitive deficits in psychiatry is not only a primary therapeutic target, but also should be conceptualized as a transdiagnostic domain to be considered regardless of patient age and/or differential diagnosis.

OriginalsprogEngelsk
TidsskriftCNS Spectrums
Vol/bind24
Udgave nummer1
Sider (fra-til)154-162
Antal sider9
ISSN1092-8529
DOI
StatusUdgivet - feb. 2019

ID: 58079932